Inotropic Drugs-Limitations in Heart Failure Flashcards
NE effects
↑ sympathetic outflow → NE effects on β-receptors (1 and 2) and α2 receptors on the myocardium
*downregulate β-1
NE Response on: □ β1, β2, α1 → □ β1, β2, α1 → □ β1, β2 → □ β1, β2 → □ β1 →
□ β1, β2, α1 → cardiac myocyte response
□ β1, β2, α1 → positive inotropic response
□ β1, β2 → positive chronotropic response
□ β1, β2 → myocyte toxicity
□ β1 → myocyte apoptosis
- too much response can lead to myocyte death/increased arrhythmias
Benefits of β-blockers
§ Prevent downregulation of B1 receptor
§ Prevent Apoptosis/Oxidative stress
§ Prevent hypertrophy/fibrosis
§ Prevent increased arrhythmia potential
- b-blockers as shield: upregulate b-1 and prevent negative effects
- reduce mortality and increase EF
When should treatment with a beta blocker be started?
- Tx with a diuretic so that patient has minimal evidence of fluid retention.
- Tx with an ACE inhibitor for at least 2 weeks.
- No recent use of IV vasodialators or positive inotropic agents
- Systolic blood pressure > 90 mmHg
- Heart rate > 60 beats/min (unless tx with a pacemaker)
- Absence of end-organ failure
Neprilysin inhibitors
example
Valsartan
Sacubitril
L8Q657
How does Neprilysin inhibitors work?
when we get additional stretch of atria or ventricles → get release of B-type natriuretic peptide (pro BNP) → converted N-terminal BNP → cleaved to BNP (which has awesome effects)
- well Neprilysin is a dick that degrades BNP. So Neprilysin inhibitors are cock blockers
Beneficial Effects of BNP
○ Vasodilator reduces afterload
○ Reduces sympathetic tone
○ Reduces aldosterone
○ Natriuresis, diuresis
HFrEF vs HFpEF
what type of dysfunction?
o Heart failure with reduced ejection fraction = HFrEF
- Left ventricular systolic dysfunction = LVSD
o HF with preserved ejection fraction = HFpEF
o Preserved systolic function = PSF
- Diastolic dysfunction
Main Mechanism of Digoxin
○ Blocks Na/K ATPase, get accumulation of Na on intracellular side
§ NCX then swaps Na for Ca
§ Increase force of contraction
§ That’s why digoxin is thought of as a weak inotrope
○ Other mechanism of digoxin:
§ Neurohormonal modulator via baroreceptors
Secondary mech of Digoxin
Neurohormonal modulator via baroreceptors
□ Indiv. can lose sensitivity when heart is overstimulated, symp nervous system is always on and para doesn’t respond well
Dig may increase parasymp activity by increasing sensitivity and decreasing symp sensitivity
*remember: digoxin is a weak inotrope that increases F of contraction
How is digoxin excreted?
Half life?
Does it have a large or narrow therapeutic window?
Renally
38 hours: takes ~7 days to get to steady state
Narrow
Which drugs used in conjunction of Digoxin will double it’s [ ]?
(meaning if you are using any of these agents, you have to drop dig levels by 50%)
Quinidine, varapamil, amiodarone, draniderone, Propafenone, itraconazole, arythromycin, Erythromycin, clarithromycin,
Digoxin toxicity:
hypokalemia
hypercalcemia
hypomagnesemia
How do patients present with Digoxin toxicity? (symptoms)
Neurological: weakness, confusion
Visual: sensitivity to light, yellow halos around eyes, blurred vision
Cardiac: bradycardia, heartblock, arrhythmias
GI: nausea vomiting, ab pain
Electrolyte: hyperkalemia
*recall: hypokalemia
hypercalcemia
hypomagnesemia
role of digoxin in patients with HFrEF
Digoxin can be beneficial in patients with HFrEF, unless contraindicated, to decrease hospitalizations for HF